Status:
UNKNOWN
Oral Oxytocin Modulation of Responses to Emotional Stimuli
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
MALE
17-32 years
Phase:
NA
Brief Summary
The main aim of the study is to investigate whether orally administered oxytocin (24IU) can modulate neural and behavioral responses to positive and negative valence stimuli during basal (emotional sc...
Detailed Description
A number of previous studies have reported both neural and social cognition effects of intranasally administered oxytocin, although it is unclear whether functional effects are mediated by the peptide...
Eligibility Criteria
Inclusion
- Healthy subjects without any past or present psychiatric or neurological disorders
Exclusion
- History of brain injury
- Head trauma
- Substance abuse
- Medication
- fMRI contraindications (e.g. metal implants)
Key Trial Info
Start Date :
February 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04320706
Start Date
February 20 2020
End Date
March 1 2021
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
school of life science and technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China, 610054